While recent studies have concluded that the neutrophils to lymphocytes ratio or NLR may be a poor indicator of cancer, new research suggests that NLR may be a helpful prognostic tool with respect to developing mesothelioma treatment protocols. The study published in Oncotarget conducted an analysis of 10 other studies which covered the cases of 1,500 mesothelioma patients.
NLR is a marker for inflammation in the body and therefore NLR provides a snapshot of the overall health of the immune system, a function vital to fight malignant cancer cells and to fight against new tumors. Improved treatment strategies could be key in extending survival times or quality of life during those survival times. NLR has also shown promise in helping approving mesothelioma patients for clinical trials.
The Paul Law Firm advocates for victims of asbestos-related diseases. If you or a loved one is suffering from mesothelioma, call the Paul Law Firm. With over 2.5 billion dollars collected for victims of asbestos exposure, we have the knowledge and the experience to fight for you. We also understand that fighting doesn’t just happen in the courtroom. It also happens in a lab where we are fighting for a cure. Check out the Mesothelioma Research Foundation of America here.
Call us today at 1-855 88 LEGAL (885-3425) or contact us online to discuss your case with one of our experienced mesothelioma lawyers
